Navigation Links
Early surgical treatment contributes to better outcomes in gallstone pancreatitis cases
Date:12/18/2007

CHICAGO (December 18, 2007) Although delaying surgical treatment remains the standard of care for patients with severe gallstone pancreatitis, a new study published in the December issue of the Journal of the American College of Surgeons shows that, contrary to widespread belief, early cholecystectomy -- or surgical removal of the gallbladder -- significantly reduces hospital stays in patients with mild to moderate gallstone pancreatitis with no increase in complications or mortality.

Gallstones -- the small, pebble-like deposits that develop in the gallbladder -- are the leading cause of acute pancreatitis (inflammation of the pancreas) in the United States. Although delaying an operation remains the standard of care for severe gallstone pancreatitis, the timing of cholecystectomy for mild to moderate gallstone pancreatitis is controversial, with many surgeons believing that the surgical procedure should be delayed until laboratory abnormalities and symptoms have resolved.

This study dispels the notion that the later the cholecystectomy, the better the outcome in patients with mild to moderate gallstone pancreatitis. We found excellent outcomes in patients undergoing the procedure within two days of hospitalization, lead investigator of the study David K. Rosing, MD, Harbor-UCLA Medical Center, said. Perhaps most importantly, we found that early cholecystectomy reduces the time these patients are in the hospital by three or four days, which benefits both the individual patient and the hospital.

Researchers conducted a cohort study consisting of a retrospective (n=177) and prospective group (n=43) to investigate the optimal timing of laparoscopic cholecystectomy for patients with mild to moderate gallstone pancreatitis. For the prospective group, cholecystectomy was performed less than 48 hours from admission, before resolution of laboratory or physical examination abnormalities were resolved. The primary endpoint was total length
'/>"/>

Contact: Sally Garneski
pressinquiry@facs.org
312-202-5409
Weber Shandwick Worldwide
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Pot bellies linked to early signs of cardiovascular disease
2. Eye-staining technique offers early detection for dry eye syndrome
3. Early Weight Loss in Women Linked to Dementia
4. Isolation of a new gene family essential for early development
5. U of M study: Early treatment can reverse heart damage
6. Gerresheimer to be Included in the SDAX Early Decision on Inclusion in the MDAX on September 5, 2007
7. Rock N Roll: Sex, Drugs and an Early Exit
8. Pop stars more than twice as likely to die an early death
9. Exercise and yoga improves quality of life in women with early-stage breast cancer
10. Research says doctors gender may hinder early diagnosis of heart disease in women
11. Antidepressant shows early promise in treating agitation and psychotic symptoms of dementia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)... significant scientific advances in the field of blood cancers, ... of how certain diseases progress in order to discover ... care. Research presented today at the 51st Annual Meeting ... therapies for managing multiple myeloma, the importance of advance ...
(Date:12/5/2009)... triggers, experts advise , , SATURDAY, Dec. 5 (HealthDay News) ... asthma can have bad reactions to certain holiday traditions ... and wheezing, according to the American College of Allergy, ... to live evergreens may choose to decorate with artificial ...
(Date:12/5/2009)... are popping up in the most unusual places, and to do everything ... ... (PRWEB) December 5, 2009 -- Who would have thought that your wine, ... Fort Worth, Texas has announced a new line of turbines, for industry ...
(Date:12/4/2009)... Holdings, Ltd (NYSE: AWH ) today announced ... Sennott, Executive Vice,President and Chief Corporate Strategy Officer, will ... Conference being held at the Goldman,Sachs Conference Center in ... About Allied World Assurance Company ...
(Date:12/4/2009)... Calif., Dec. 4 Pamela Bowen, Chief Information Officer ... the "Chief Innovation Officer" Appy Award for transforming Crescent,s ... recipients are nominated based on their innovative usage of ... levels of customer success to their sales, marketing, partner, ...
Breaking Medicine News(10 mins):Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 4Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 5Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 6Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 7Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 8Health News:Keep Asthma, Allergies at Bay for the Holidays 2Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2
... help keep extra pounds at bay, expert says , SUNDAY, Dec. ... of the holidays, it,s all too easy to pack on extra ... bit of planning may help you avoid weight gain, says Jennifer ... University. , "It,s OK to indulge in a little of your ...
... U2,s Bono and Others Challenge 5,000 Teens via, Simulcast to 200 Locations ... ... Cure, LAKE FOREST, Calif., Dec. 1 First ... Church, held on World AIDS Day, which capped a,four-day Global Summit on AIDS ...
... Everything from Christmas trees to fake snow can trigger symptoms, ... It,s easy for the holidays to become the season ... or other allergies and asthma, say experts at the American ... preventive measures can cut symptoms to a minimum, they say. ...
... Children Living with HIV Stand to Benefit from ... ... made its new,lower- strength lopinavir/ritonavir (LPV/r) tablet, known as Aluvia(R) in,developing ... in Uganda -- a step the company hopes will,begin to improve ...
... VA As the obesity epidemic grows in ... far reaching health concerns for overweight children. Sleep-disordered ... ranging in severity from snoring to obstructive sleep ... and African- American, according to a new study ...
... Awareness of Disease, Funding for Research, SAN JOSE, Calif., ... death defying stunts and his recovery from,life threatening injuries due ... life was one that has no treatment and no cure. ... will lose their,lives to idiopathic pulmonary fibrosis (IPF) this year, ...
Other Medicine News:Health News:Holidays Don't Have to Leave You Heavier 2Health News:First-Ever Saddleback AIDS Youth Summit Addresses a Future Without HIV On World Aids Day: 2Health News:First-Ever Saddleback AIDS Youth Summit Addresses a Future Without HIV On World Aids Day: 3Health News:'Tis the Season For Allergy, Asthma 2Health News:Ugandan Children Are Among the First to Receive Abbott's Lower-Strength Aluvia (lopinavir/ritonavir) Tablet 2Health News:Ugandan Children Are Among the First to Receive Abbott's Lower-Strength Aluvia (lopinavir/ritonavir) Tablet 3Health News:Ugandan Children Are Among the First to Receive Abbott's Lower-Strength Aluvia (lopinavir/ritonavir) Tablet 4Health News:Ugandan Children Are Among the First to Receive Abbott's Lower-Strength Aluvia (lopinavir/ritonavir) Tablet 5Health News:Ugandan Children Are Among the First to Receive Abbott's Lower-Strength Aluvia (lopinavir/ritonavir) Tablet 6Health News:Ugandan Children Are Among the First to Receive Abbott's Lower-Strength Aluvia (lopinavir/ritonavir) Tablet 7Health News:Ugandan Children Are Among the First to Receive Abbott's Lower-Strength Aluvia (lopinavir/ritonavir) Tablet 8Health News:Childhood sleep-disordered breathing disproportionately affects obese and African-Americans 2Health News:Evel Knievel Lost to Pulmonary Fibrosis; Disease Claims as Many Lives as Breast Cancer Each Year 2
(Date:12/4/2009)... Imaging, LLC, an independent provider of CT, MRI ... and healthcare providers, is excited to announce it ... Health Care, a nationally-recognized, prestigious gold seal of ... Shared Imaging accreditation is system-wide for its mobile ...
(Date:12/4/2009)... Hospira, Inc. (NYSE: HSP ), a leading ... the launch of its next-generation 50 mL and 100 ... and now offers a complete size range (50 mL ... product. The launch of the 50 mL and 100 ...
(Date:12/4/2009)... Suneva Medical, a privately-held aesthetic medical device company, ... President and Chief Financial Officer. In this role, ... administrative functions including finance, accounting, IT, IR, administration and ... Company,s senior management team. ,, "One of my ...
Breaking Medicine Technology:Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 3Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 4eCube Delivers Linux on System z Support for NXTera High Performance Middleware 62413 1eCube Delivers Linux on System z Support for NXTera High Performance Middleware 62413 2eCube Delivers Linux on System z Support for NXTera High Performance Middleware 62413 3Outpatient Disc Treatment Gives Long Term Back Pain Relief 62408 1Outpatient Disc Treatment Gives Long Term Back Pain Relief 62408 2Outpatient Disc Treatment Gives Long Term Back Pain Relief 62408 3AMT Announces Management Changes in Light of Refocused Strategy 6665 1AMT Announces Management Changes in Light of Refocused Strategy 6665 2AMT Announces Management Changes in Light of Refocused Strategy 6665 3
... Cougar Biotechnology,Inc. (OTCBB:CGRB) today announced that positive Phase ... cancer drug candidate CB7630,(abiraterone acetate) was presented at ... currently taking place,in Anaheim, California. The data was ... Research UK Centre for Cancer Therapeutics at,The Institute ...
... WIRE)--May 21, 2007 - Medical,professionals seeking to ... gram-negative pneumonia may have a new weapon:,NKTR-061 ... by Nektar Therapeutics (Nasdaq:NKTR)., Results of a ... of,NKTR-061 (Inhaled Amikacin) to treat mechanically ventilated,patients ...
Other Medicine Technology:Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at AUA Annual Meeting 2Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at AUA Annual Meeting 3Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at AUA Annual Meeting 4Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 2Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 3Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 4Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 5Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 6Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 7Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 8Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 9Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 10Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 11
... Surgical Table combines innovation and design to ... to 1,000 lbs. You can safely raise ... and reverse orientation and have virtually the ... Amsco 3085 SP Table offers the same ...
... important part in our daily lives. But ... can cause severe handicaps. A decisive consideration ... was to produce a reconstructed joint function ... nearly possible.,The cementless RM Finger System has ...
... part in our daily lives. But degenerative ... cause severe handicaps. A decisive consideration in ... to produce a reconstructed joint function that ... possible.,The cementless RM Finger System has proven ...
... The Low Profile Leg Holder provides precise ... lower leg rotation, and maximum exposure of the ... Low Profile Leg Holder can be used on ... adjusted to different heights.,The Low Profile Leg Holder ...
Medicine Products: